Articles about insulin resistance often begin with a list of warning signs. The honest place to begin is different: insulin resistance usually has no symptoms. Federal health guidance says people with insulin resistance and prediabetes usually have none, and the Centers for Disease Control and Prevention notes that you cannot tell whether someone has insulin resistance by looking at them.
So the early signs are not things you feel. They are patterns in your history and your lab work. This article explains what those patterns are, and how insulin resistance is evaluated.
The signs that show up in your history
Certain factors make insulin resistance more likely. The National Institute of Diabetes and Digestive and Kidney Diseases lists:
Having overweight, obesity, or a large waist size
Being 35 or older
Not being physically active
Certain conditions, including polycystic ovary syndrome, or PCOS, and sleep apnea
Certain medicines, including glucocorticoids, some antipsychotics, and some HIV medicines
The CDC adds a family history of type 2 diabetes. It also makes a point that is easy to miss: overweight and obesity are risk factors, but you do not need them to have insulin resistance.
For women, three histories deserve particular attention: PCOS, sleep apnea, and gestational diabetes. PCOS and sleep apnea are listed among the conditions linked to insulin resistance, and the NIDDK lists a history of gestational diabetes among the risk factors that call for prediabetes screening. Any of the three is a reason to check.
The signs that show up in your lab work
Because there is usually nothing to feel, lab results are where insulin resistance tends to appear first. The CDC lists several results as risk factors:
Higher blood sugar
High triglycerides
High LDL cholesterol
Low HDL cholesterol
None of these confirms insulin resistance on its own. Together, and alongside your history, they form a pattern worth taking seriously.
There is a related finding in the liver. Metabolic dysfunction-associated steatotic liver disease, or MASLD, previously called nonalcoholic fatty liver disease, is listed by the NIDDK as a health problem related to insulin resistance and prediabetes.
How it is evaluated
Here again, honesty helps. The formal test for insulin resistance is used mainly in research studies, and clinicians may not test for it directly. In practice, evaluation relies on established tests that show where blood sugar stands, read alongside the pattern described above.
Tests that diagnose prediabetes. The NIDDK defines prediabetes by these results:
A1C: 5.7% to 6.4%
Fasting plasma glucose: 100 to 125 mg/dL
Oral glucose tolerance test, 2 hours: 140 to 199 mg/dL
For women with PCOS, the 2023 international PCOS guideline recommends the oral glucose tolerance test, because A1C and fasting glucose can miss blood sugar changes that it finds.
A lipid panel. Triglycerides and HDL cholesterol are part of the pattern, and they are measured on a standard lipid panel.
Fasting insulin, as context. A fasting insulin test measures how much insulin the pancreas is producing. Because insulin levels vary with blood glucose, a single result is usually not enough on its own, and it is read alongside fasting glucose and A1C. Reference ranges vary between laboratories. Used this way, it can help show whether the body is compensating before glucose rises. It is not a stand-alone diagnosis.
Your history. Waist size, activity, sleep, family history, PCOS, medicines, and any history of high blood sugar all belong in the evaluation. The numbers make more sense with the history attached.
Why it is worth finding early
The reason to look for insulin resistance before glucose rises is that this is when change does the most good.
In the Diabetes Prevention Program, a large federal trial of people at high risk for type 2 diabetes, a lifestyle program aimed at 7 percent weight loss and 150 minutes of activity a week lowered the chance of developing type 2 diabetes by 58 percent over about three years. In participants aged 60 and older, the reduction was 71 percent. Long-term follow-up found that the lifestyle and metformin groups continued to prevent or delay type 2 diabetes for at least 15 years.
The CDC describes what improves insulin sensitivity: physical activity, weight loss for people with overweight or obesity, balanced eating that lowers blood sugar, managing stress, and getting enough sleep.
What to ask
If any of the history or lab patterns above apply to you, three questions are worth raising with your clinician. When were my A1C and fasting glucose last checked? Do my triglycerides and HDL suggest a pattern? And do any of my conditions or medicines raise my risk?
Insulin resistance is quiet. Finding it depends on looking for it on purpose.
The Energē Editorial answers one question like this each month, with sources printed in full. Join the Editorial.
If you are located in Virginia and would like your own picture evaluated, request an Energē Introduction.
This article is general education. It is not medical advice and does not replace care from your own clinician.
Sources
National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes. Last reviewed March 2025.
Centers for Disease Control and Prevention. Insulin Resistance and Type 2 Diabetes. May 15, 2024.
MedlinePlus, National Library of Medicine. Insulin in Blood. Last updated September 30, 2026.
National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program (DPP).
National Institute of Diabetes and Digestive and Kidney Diseases. Risk Factors for Diabetes. Last reviewed October 2015.
Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism. 2023;108(10):2447–2469.
